A Phase 1, Open-Label, Dose-Escalation Trial to Investigate Safety and Tolerability of Single Intravitreous Injections of ICON-1 Targeting Tissue Factor in Wet AMD. - Wells JA; Gonzales CR; Berger BB; Gonzalez VH; Sippy BD; Burian G (Ophthalmic surgery, lasers & imaging retina, 2018)